2019 News

Vancouver BC / NEWSWIRE / February 19, 2019 /CNW/ - Agrios Global Holdings Ltd. (CSE: AGRO) (FSE: ØSA - WKN-A2N62K) ("Agrios" or the "Company") is pleased to announce the appointment of Mr. Robert Lanterman, as VP Product Development.


  • Former Director of Sales at Organa Brands, now Slang Worldwide (CSE: SLNG)
  • Lanterman possesses strong understanding of product development in the highly regulated cannabis environment
  • Responsible for the build-out of Organa's sales and distribution platform selling products across the United States and in 11 countries
  • 25+ years business/product development of luxury brands

Robert Lanterman is a highly qualified product development and marketing professional with extensive experience in both the luxury brands and cannabis sectors. During his early career Robert developed numerous luxury product lines for key accounts including Marshall Fields now Macy's, Neiman Marcus, Bergdorf Goodman, Holt Renfrew and Saks 5th Avenue. Robert was responsible for P & L, critical design input, and oversight of line merchandising and budget planning. Robert has been highly effective at building out regional sales teams, and overseeing all management levels of both domestic and international business divisions.

As director of wholesale at Gucci International, Robert conceptualized and launched the popular "store within a store" marketing style. This innovative retail concept enabled lifestyle brands including Gucci, Ralph Lauren, and Organa, to extend their market reach by maximizing visibility with minimal capital outlay.

While at Organa, Robert led the development and execution of numerous product categories from concept to shelf. Organa, now Slang (CSE: SLNG) backed by Canopy Growth, was a pioneer brand incubator, that revolutionized the cannabis trade with the development of supercritical CO₂ extracted cannabis oil in 2010 followed by the launch of the leading-edge O.pen-VAPE device in 2012. Numerous other products followed, including Bakked, Craft Reserve, Magic Buzz, District Edibles and Pressies.

In December 2017, the Daily Beast reported that Organa, along with Canopy Growth was one of the largest cannabis companies in North AmericaAlthough a private company at the time of Robert's tenure, Organa is reputed to have generated revenues in excess of US $100 million per annum, with the distinction of selling a vape every 7 seconds, 24/7, 365 days per year. * 

Robert will be responsible for all aspects of creating and launching the Company's exciting new Product Development unit. His extensive sales and marketing acumen with a diverse palette of products will benefit Agrios as the Company expands to create additional revenue streams for healthy sustained growth.

The new VP stated: "I look forward to establishing an innovative range of products that will resonate with the current consumer market, and I am delighted to join Agrios and assist the Company to develop to its full potential."

"Agrios will be continuing its expansion into multiple markets in the United States." said Agrios President & CEO, Chris Kennedy, "We are excited to have acquired Robert's services. His comprehensive understanding of cannabis product development, branding and marketing combined with his extensive experience in creative new product launches and sales will facilitate the Company's move to create multiple revenue streams. We look forward to growing Agrios with Robert and welcome him to the Agrios team."

About Agrios Global Holdings Ltd.

Agrios Global Holdings is a data analytics driven agriculture technology and services company advancing the latest innovations in indoor growing science. The Company owns, leases and manages properties and equipment for eco-sustainable agronomy and provides advisory services to support all aspects of aeroponic cultivation in the cannabis sector. Agrios is actively pursuing new opportunities to expand its portfolio of tenant growers and infrastructure assets in strategic licensed jurisdictions. Based in Vancouver, BC. Agrios is managed by a highly accomplished team of experienced industry and capital markets experts who are committed to the growth of the company.

*information provided by several Sr. Executives at Organa December 2017.

For further information please contact:

Ute Koessler
T: 604-336-2444                            

Bettina Filippone
T: 514.939.3989


Agrios Global Holdings Ltd.

This news release was prepared by management of Agrios, which takes full responsibility for its contents. The Canadian Securities Exchange (" CSE ") has not reviewed and does not accept responsibility for the adequacy of this news release.  Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Agrios' periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to corporate strategy and Agrios' ability to execute such strategy, future developments regarding Agrios' expansion into various markets including numerous states within the United States of America, and into Asia, expected costs of hemp fiber, intended development and sales of hemp products, market demand for hemp products, and the business and operations of Agrios as it relates to the Yunnan Province.

Although Agrios has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Agrios disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Agrios does not assume any liability for disclosure relating to any other company mentioned herein.

Subscribe for email updates